Filing Flows › Alto Ingredients (ALTO) › Q3 2026 › vs Q3 2025
Alto Ingredients (ALTO) Q3 2026 vs Q3 2025 (year over year)
Alto Ingredients's revenue rose $16.9M (+7%) from $241M in Q3 2025 to $258M in Q3 2026. Gross margin 5.7% against 9.7% (-4.0 pts).
Alto Ingredients, Q3 2026: revenue $258M (+7% year over year), operating margin 2.7%, net earnings $13.0M, operating cash flow $12.9M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 5.7% | 9.7% | -4.0 pts |
| Operating margin | 2.7% | 7.0% | -4.3 pts |
| Net margin | 5.0% | 5.9% | -0.8 pts |
| Free cash flow margin | 3.3% | 8.8% | -5.5 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $258M | $241M | $16.9M | +7% |
| Gross profit | $14.8M | $23.5M | −$8.7M | -37% |
| Cost of revenue | $243M | $217M | $25.6M | +12% |
| Other income, net | $6.0M | −$2.8M | $8.8M | — |
| Operating profit | $7.0M | $17.0M | −$10.0M | -59% |
| Operating expenses | $7.8M | $6.5M | $1.3M | +20% |
| Pre-tax earnings | $13.0M | $14.2M | −$1.2M | -8% |
| Net earnings | $13.0M | $14.2M | −$1.2M | -8% |
| Depreciation & amortization | $6.7M | $6.3M | $431K | +7% |
| Share-based compensation | $908K | $706K | $202K | +29% |
| Working capital & other | $7.8M | −$1.6M | $9.4M | — |
| Operating cash flow | $12.9M | $22.8M | −$9.9M | -44% |
| Free cash flow (OCF − capex) | $8.5M | $21.2M | −$12.7M | -60% |
| Capital expenditures | $4.4M | $1.6M | $2.8M | +169% |
Questions
How much did Alto Ingredients's revenue grow year over year in Q3 2026?
Alto Ingredients's revenue rose $16.9M (+7%) from $241M in Q3 2025 to $258M in Q3 2026. Gross margin 5.7% against 9.7% (-4.0 pts).